Fennec Pharmaceuticals, Inc. (FENC)
7.92
+0.12
(+1.54%)
USD |
NASDAQ |
Mar 17, 09:53
Fennec Pharmaceuticals Total Liabilities (Quarterly) : 53.75M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 121.38B |
| REGENXBIO, Inc. | 350.30M |
| Zymeworks, Inc. | 78.03M |
| Apellis Pharmaceuticals, Inc. | 705.11M |
| Gossamer Bio, Inc. | 291.15M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 49.26M |
| Shareholders Equity (Quarterly) | -4.492M |
| Debt to Equity Ratio | -4.031 |
| Current Ratio | 4.693 |
| Net Debt Paydown Yield | 0.89% |